RESOURCES

Read

​​​ARTICLES / BLOGS / EDITORIALS

"Why open source pharma is the path to both new and cheaper medicines" by Matthew Todd, The Guardian

"What is Open Source Pharma (and Why Should You Care)?" by Andy Updegrove, Slashdot

"Message from Chief Mentor" by Samir Brahmachari, OSDD 

"Prof Samir K. Brahmachari, Chief Mentor OSDD" on Open Source Drug Discovery

"How open-source medicine could prepare us for the next pandemic" by Ruth Reader, Fast Company

"If tuberculosis spreads..." by Polly J. Price, The NY Times

"Open Source Pharma and Prizes" by Matthew Todd, Intermolecular

"Talking drug prices, Pt 6: Openness vs. secrecy in drug development" by Matthew Todd, PLOS

"Four Reasons Drugs are Expensive, Of which Two are False" by Jack Scannell, Forbes

"Billion-dollar babies - The high cost of R&D is used to explain why drugs giants merge, and why they must charge high prices. The reality is somewhat different", The Economist

"A question of utility: Patents are protected by governments because they are held to promote innovation. But there is plenty of evidence that they do not", The Economist
​
"Can Open Source Drug Development Deliver?" by Tatum Anderson, The Lancet 
​
"Can open science help patients and save pharma?" by Timothy King
​
"International team of scientists open sources search for malaria cure" by Alice Williamson
​
"Making drug development less secretive could lead to quicker, cheaper therapies" by Matthew Todd and Alice Williamson

"Patents are eating the world and hurting innovation" by Walter Frick 

"Rallying pharma's rebels" by Matthew Herper, Forbes 
​
"Drugs for the poor, drugs for the rich—why the current research and development model doesn’t deliver" by Manica Balasegaram, BMJ

"A New Look At The Most Innovative Pharma Companies (And Whether They Are Sustainable) -- Part I" by Bernard Munos, Forbes

"Beyond Heroism And Denial: How To Fortify Our Response To Ebola" by Bernard Munos, Forbes

"We the People vs. the Pharmaceutical Industry" by Bernard Munos, Forbes

"Pharmaceutical innovation gets a little help from new friends" by Bernard Munos​
​
"Tata Trusts Support OSPF - the 'Linux for Drugs'" by PT Jyothi Datta, The Hindu

"Linux for Drugs", BioSpectrum Bureau

"The Collateral Benefits of India's Open Source Drug Discovery Programme" by Priyanka Pulla, Forbes India

"How Open Source Drug Discovery Is Helping India Develop New Drugs" by Seema Singh, Forbes India

"The R-Factor: A Measure of Scientific Veracity" by Joshua Nicholson and Yuri Lazebnik, The Winnower

"System, crowd, and communal innovation: Can the monks solve the elephant?" by Shinya Ito 



REPORTS / PAPERS

​FDA clears IND for first clinical trial protocol developed using crowdsourcing (multiple articles)

​"Prizes, not patents" by Joseph E. Stiglitz
​
"PUSH, PULL, POOL: Accelerating Innovation and Access to Medicines for Tuberculosis" by Medicines Sans Frontieres 
(PDF long version)

"The Role of Patent Law in Regulating and Restricting Access to Medicines" by Luigi Palombi

"Prize-driven Innovation for Development" by the Indian Institute of Technology Delhi, Jaykumar Menon, and Ambuj Sagar (PDF version)

"Crowd computing: using competitive dynamics to develop and refine highly predictive models" by Joerg Bentzien, I. Muegge, B. Hamner, and D.C. Thompson

"Working towards sustainable software for science: Practice and experiences," a collection of papers curated by Matthew Turk

"Crowdsourcing clinical trial protocols" by Robert H. Carlson​
​
​
OTHER

Sage Bionetworks: Challenges

U.S. Medical Innovation Prize Fund Act, introduced by Senator Bernie Sanders​

"Incentives needed to further improve sharing of research data, says new report", Welcome Trust 2013 Press release

 ​Watch / Listen

​VIDEOS

Balance Magazine interview with Samir Brahmachari on NRK, a Norwegian TV network
​
​"Open Source Drug Discovery (OSDD) song - tuberculosis",  featuring students singing about TB research 

"Bitten by the Bug" Melinda Richter, head of Janssen Labs, speaks at TEDxAmericasFinestCity

"Kshaya Rog: Nayee Davayen, Nayee Chunatiyan Nayee Ashayen" produced by Dr. Jayanti Dutta
5-minute short film by a child about TB

"Need of new drugs for TB: We need this" produced by Srigireesh Rasiappan
4-minute short film by students at PSG Institute of Medical Sciences and Research

"Beyond open access: Sharing research-derived knowledge with society," an interview with Dr. John Willinsky, founder and director of the Public Knowledge Project

Osdd videos

​PODCASTS

"Entrepreneur joins group effort to cure millions" by Your Mark on the World with Jaykumar Menon​

BACK TO TOP